
Last update at 2026-03-11T13:48:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Form 8.3 - 8389392 PROPERTIES PLC
Wed 13 Aug 25, 02:00 PMTMR Capital (PTC) Limited’s View on the Assura plc Acquisition Offers
Mon 11 Aug 25, 07:56 PMBidding battle for Assura heats up as competition watchdog takes further action
Fri 08 Aug 25, 07:26 AMAssura Group Rejects KKR & Co. Inc. (KKR) Takeover Bid in Favor of Competitor $2.4 Billion Offer
Mon 30 Jun 25, 01:47 AMForm 8.3 - Primary Health Properties plc - Amendment
Fri 27 Jun 25, 02:00 PMDimensional Fund Advisors Ltd. : Form 8.3 - PRIMARY HEALTH PROPERTIES - Ordinary Shares
Thu 26 Jun 25, 10:38 AMForm 8.3 - Primary Health Properties Plc
Wed 18 Jun 25, 02:07 PMForm 8.3 - Primary Health Properties
Tue 17 Jun 25, 06:00 AM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 56.90M | 141.60M | 112.40M | -70.20000M | 74.30M |
| Minority interest | - | - | - | - | - |
| Net income | 56.30M | 140.10M | 112.00M | -71.30000M | 74.30M |
| Selling general administrative | 4.20M | 4.20M | 2.50M | 2.20M | 0.90M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 85.70M | 222.70M | 128.60M | -46.50000M | 76.40M |
| Reconciled depreciation | - | - | - | - | - |
| Ebit | 131.90M | 126.20M | 118.00M | 103.40M | 66.50M |
| Ebitda | 97.40M | 141.60M | 112.40M | -70.20000M | 101.00M |
| Depreciation and amortization | - | - | - | - | - |
| Non operating income net other | - | - | - | - | - |
| Operating income | 97.40M | 141.60M | 112.40M | -70.20000M | 66.50M |
| Other operating expenses | 28.80M | 81.10M | 16.20M | 13.50M | - |
| Interest expense | 40.50M | 39.50M | 42.20M | 39.90M | 26.70M |
| Tax provision | 0.60M | 1.50M | 0.40M | 1.10M | 0.00000M |
| Interest income | 2.30M | 1.10M | 1.20M | 1.40M | 0.10M |
| Net interest income | -38.20000M | -38.40000M | -40.30000M | -38.50000M | -26.60000M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 0.60M | 1.50M | 0.40M | 1.10M | - |
| Total revenue | 85.70M | 222.70M | 128.60M | -46.50000M | 84.00M |
| Total operating expenses | 28.80M | 81.10M | 16.20M | 13.50M | 8.70M |
| Cost of revenue | - | - | 7.80M | 5.60M | 3.20M |
| Total other income expense net | -40.50000M | -39.50000M | -42.20000M | -39.90000M | 7.80M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 56.30M | 140.10M | 112.00M | -71.30000M | 74.30M |
| Net income applicable to common shares | 56.30M | 140.10M | 112.00M | -71.30000M | 74.30M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-06-30 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | - | 2864.50M | 2853.10M | 2697.10M | 2573.40M |
| Intangible assets | - | - | - | - | - |
| Earning assets | - | - | - | - | - |
| Other current assets | - | 6.00M | 5.40M | 7.10M | 5.90M |
| Total liab | - | 1382.30M | 1353.20M | 1282.70M | 1344.90M |
| Total stockholder equity | - | 1482.20M | 1499.90M | 1414.40M | 1228.50M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | - | -3.30000M | -40.00000M | -0.70000M | -0.20000M |
| Common stock | - | 167.10M | 166.60M | 164.40M | 152.00M |
| Capital stock | - | 167.10M | 166.60M | 164.40M | 152.00M |
| Retained earnings | - | 430.10M | 460.50M | 402.60M | 298.50M |
| Other liab | - | 5.40M | 4.40M | 3.50M | 3.10M |
| Good will | - | - | - | - | - |
| Other assets | - | 2803.60M | 2802.00M | 2697.10M | 2413.10M |
| Cash | - | 29.10M | 33.40M | 103.60M | 143.10M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | - | 3.30M | 40.00M | 0.70M | 0.20M |
| Current deferred revenue | - | - | - | - | - |
| Net debt | - | 1273.50M | 1246.30M | 1113.80M | 1125.30M |
| Short term debt | - | - | - | - | 6.10M |
| Short long term debt | - | - | - | - | 6.10M |
| Short long term debt total | - | 1302.60M | 1279.70M | 1217.40M | 1268.40M |
| Other stockholder equity | - | 885.00M | 872.80M | 847.40M | 778.00M |
| Property plant equipment | - | 2796.70M | 2796.20M | 2576.10M | 2413.10M |
| Total current assets | - | 40.90M | 45.60M | 114.20M | 159.80M |
| Long term investments | - | 19.60M | 5.20M | - | 0.50M |
| Net tangible assets | - | 1482.20M | 1499.90M | 1414.40M | 1228.50M |
| Short term investments | - | - | - | - | - |
| Net receivables | - | 11.80M | 12.20M | 10.60M | 16.70M |
| Long term debt | - | - | - | 1206.50M | 1271.30M |
| Inventory | - | 1.30M | 0.70M | - | - |
| Accounts payable | - | 3.30M | 40.00M | 0.70M | 0.20M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | - | - | - | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | 164.40M | 152.00M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | - | -20.00000M | -5.50000M | - | -0.50000M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | - | 20.00M | 5.50M | - | 0.50M |
| Capital lease obligations | - | - | - | - | - |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -45.80000M | -146.40000M | -100.90000M | -55.80000M | -101.90000M |
| Change to liabilities | -12.90000M | 15.90M | 4.20M | 7.80M | 1.40M |
| Total cashflows from investing activities | -45.80000M | -146.40000M | -100.90000M | -55.80000M | -101.90000M |
| Net borrowings | 48.80M | 82.80M | -58.40000M | 110.50M | -5.60000M |
| Total cash from financing activities | -76.90000M | -63.60000M | -58.10000M | 100.70M | 34.80M |
| Change to operating activities | - | - | - | - | - |
| Net income | 56.30M | 140.10M | 112.00M | -71.30000M | 74.30M |
| Change in cash | -4.30000M | -70.20000M | -39.50000M | 137.20M | 2.10M |
| Begin period cash flow | 33.40M | 103.60M | 143.10M | 5.90M | 3.80M |
| End period cash flow | 29.10M | 33.40M | 103.60M | 143.10M | 5.90M |
| Total cash from operating activities | 117.60M | 140.40M | 118.90M | 94.00M | 68.50M |
| Issuance of capital stock | 0.00000M | 0.00000M | 140.00M | 100.00M | 115.00M |
| Depreciation | - | - | - | - | - |
| Other cashflows from investing activities | 1.50M | 0.70M | 1.90M | 0.30M | 0.30M |
| Dividends paid | 81.60M | 74.40M | 69.10M | 54.40M | 34.70M |
| Change to inventory | - | - | - | - | - |
| Change to account receivables | -0.70000M | -0.30000M | -1.30000M | -5.20000M | 2.20M |
| Sale purchase of stock | - | - | -31.40000M | 298.40M | 115.00M |
| Other cashflows from financing activities | 180.40M | 263.60M | -21.40000M | -7.80000M | 128.50M |
| Change to netincome | 74.90M | -15.30000M | 4.00M | 162.70M | -9.40000M |
| Capital expenditures | 0.00000M | 0.00000M | 0.00000M | 47.70M | 0.00000M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -13.60000M | 15.60M | 2.90M | 2.60M | 3.60M |
| Stock based compensation | - | - | - | - | - |
| Other non cash items | 74.90M | -15.30000M | 4.00M | 162.70M | -9.40000M |
| Free cash flow | 117.60M | 140.40M | 118.90M | 141.70M | 68.50M |
Sector: Real Estate Industry: REIT - Healthcare Facilities
| Company | Change (GBX) | Price (GBX) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | |
|---|---|---|---|---|---|---|---|---|
| PHP Primary Health Properties |
-0.9551 0.93% | 101.24 | - | 14.84 | 8.81 | 0.92 | 70.21 | |
| THRL Target Healthcare REIT Ltd |
-1.245 1.22% | 101.16 | - | 14.35 | 7.47 | 0.82 | 5.13 | 26.25 |
| LABS Life Science REIT PLC |
-0.8 2.00% | 39.20 | - | - | 37.01 | 0.69 |
Primary Health Properties (PHP) is the leading investor in modern healthcare properties in the UK & Ireland. PHP is a UK based Real Estate Investment Trust (REIT) with a clear objective to create progressive returns to shareholders through a combination of earnings growth and capital appreciation. PHP achieve this by investing in healthcare real estate let on long-term leases, backed by a secure underlying covenant funded mostly by government bodies. The Group's portfolio comprises over 480 primary healthcare facilities, both completed and committed, the majority of which are GP surgeries, with other properties let to NHS organisations, pharmacies and dentists.
Greener House, London, United Kingdom, SW1Y 4RF
| Name | Title | Year Born |
|---|---|---|
| Mr. Richard Howell ACA, BA (Hons) | CFO & Director | 1966 |
| Mr. Harry Abraham Hyman | Founder, CEO & Director | 1956 |
| Ms. Michelle Whitfield B.Sc., MRICS | Director of Operations & Sustainability | NA |
| Mr. David Bateman BA, MRICS | Chief Investment Officer | NA |
| Mr. David Austin | Director of Asset Management | NA |
| Mr. Jesse Putzel | Director of ESG | NA |
| Mr. Paul Wright | Company Sec. | NA |
| Mr. Tim Walker-Arnott BSc, FRICS | Advisory Director | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.